Brief: Zymeworks Said To Near $929 Million Deal For Theravance - Bloomberg News
29/06/2026 10:23
BRIEF-Zymeworks Said To Near $929 Million Deal For Theravance - Bloomberg News June 29 (Reuters) -
ZYMEWORKS SAID TO NEAR $929 MILLION DEAL FOR THERAVANCE - BLOOMBERG NEWS
ZYMEWORKS IS DISCUSSING PAYING $17 PER SHARE FOR THERAVANCE- BLOOMBERG NEWS
Source https://tinyurl.com/363926nk
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zymeworks
See all newsUS STOCKS ON THE MOVE-Huron Consulting, RingCentral, Selective Insurance
U.S. STOCKS ON THE MOVE-Huron Consulting, Crown Castle, Bloom Energy
US STOCKS ON THE MOVE-Booz Allen Hamilton, SLB, Deckers Outdoor
US STOCKS ON THE MOVE-American Express, Gorman-Rupp, Moderna
Zymeworks gains on up to $813 million Roche licensing deal for lung cancer drug